Please login to the form below

Not currently logged in
Email:
Password:

Thomas Wellner appointed CEO of CML Healthcare

Former president and general manager of Lilly Germany joins Canada-based provider of laboratory testing services

Former president and general manager of Lilly Germany Thomas Wellner has been appointed CEO of CML Healthcare.

Wellner takes over from company chair Patrice Merrin, who had been interim CEO of the Canada-based provider of laboratory testing services since May, 2011.

"We are very pleased to welcome Tom Wellner to CML,” said Merrin. “During the course of his career, Tom has had exposure to numerous healthcare and payor systems as well as to the critical interface of diagnostics, physicians, patients and treatment regimens.”

Prior to his new appointment, Wellner was president and CEO of Canadian biopharma Therapure Biopharma, from 2008 to 2011.

Before his time at Theapure he spent a total of 20 years at Eli Lilly & Company holding senior roles in China, the US, the UK and Latin America.

These included executive director marketing and sales, European Operations at Eli Lilly and Company and director marketing at Eli Lilly Canada, as well as his position in Germany.

9th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics